LATE-BREAKING ABSTRACT: Sweetening Antibiotic Treatment for Eradication of Bacteria Biofilm

H. X. Ong, C. Y. Loo, W. H. Lee, D. Traini, C. Whitchurch, P. Young (Southampton, United Kingdom; Sydney, Australia)

Source: International Congress 2014 – Cystic fibrosis: assessment and treatment
Session: Cystic fibrosis: assessment and treatment
Session type: Oral Presentation
Number: 3443
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. X. Ong, C. Y. Loo, W. H. Lee, D. Traini, C. Whitchurch, P. Young (Southampton, United Kingdom; Sydney, Australia). LATE-BREAKING ABSTRACT: Sweetening Antibiotic Treatment for Eradication of Bacteria Biofilm. Eur Respir J 2014; 44: Suppl. 58, 3443

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bacterial Contamination of Home Nebulizers in Children with Cystic Fibrosis and Clinical Implication on the Number of Pulmonary Exacerbations
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019


Clinics of Cystic Fibrosis Patients with Unusual Bacteria Isolated fromRespiratory Cultures
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Bronchiectasis: Bacteriological profile
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014


LATE-BREAKING ABSTRACT: Molecular and Phenotypic Characters of Methicillin-resistant Staphylococcus aureus Isolates from Patients with Empyema Thoracis in Central Taiwan
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014


Targeting Antibiotics to Pseudomonas aeruginosa in Small airways (TAPAS) in patients with Cystic Fibrosis
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video
Source: International Congress 2014 – Bayer Expert Forum at ERS 2014 ‘Infection, Exacerbation and Colonisation: Managing Pseudomonas aeruginosa in non-CF Bronchiectasis’ – Full Video
Year: 2014

Bacterial Colonization of Airway Stents and The Effect of Colonization on Stent Course
Source: Virtual Congress 2020 – Interventional pulmonology: diagnostic and therapeutic approaches
Year: 2020


Imaging in Pleural Infections: The Radiation Adds Up
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017

Bacterial colonization in patients with bronchiectasis
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014


LATE-BREAKING ABSTRACT: Role of Interferon-á2b and Ribavirin in MERS-CoV Infection as Treatment and Prophylaxis
Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients
Year: 2014


Natural Variability of Clinically Measured Lung Clearance Index in Children with Cystic Fibrosis
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021



Applying Modern Molecular Microbiological Techniques to Identify Treatable Chronic Bacterial Airway Infection in Severe Asthma
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020




Ventilator-Induced Lung Injury Increases Systemic Inflammation in Murine Pseudomonas Aeruginosa Pneumonia
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019

Cystic Fibrosis Patients Eligible for Modulator Drugs: Data from Cystic Fibrosis Registry of Turkey
Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Year: 2019

Bronchial Lavage Exosome miRNA Correlates to Metabolic Disturbance in Patients with Pulmonary Acinetobacter Baumannii Infection
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019


Pulmonary actinomycosis: Successful treatment with oral antibiotics
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013


Aminoglycoside use for pseudomonas aeruginosa in bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019


Microbiome in Cystic Fibrosis Exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019